3-(trimethylsilyl)propanesulfonic acid: used as a hydrophobic probe for proton magnetic resonance studies of apolar sites on proteins; RN given refers to Na salt
ID Source | ID |
---|---|
PubMed CID | 5167273 |
CHEBI ID | 195173 |
SCHEMBL ID | 424021 |
MeSH ID | M0054409 |
Synonym |
---|
nsc-83558 |
AKOS003398568 |
3-(trimethylsilyl)-1-propane sulfonic acid, sodium salt |
2039-96-5 |
sodium 3-sulfopropyltrimethylsilane |
sodium 3-(trimethylsilyl)propane sulfonate |
1-propanesulfonic acid, 3-(trimethylsilyl)-, sodium salt |
3-(trimethylsilyl)propanesulfonic acid |
dss sodium salt |
sodium 3-(trimethylsilyl)propane-1-sulfonate |
3-(trimethylsilyl)-1-propanesulfonic acid sodium salt |
T1638 |
sodium 3-(trimethylsilyl)-1-propanesulfonate |
sodium 2,2-dimethyl-2-silapentane-5-sulfonate |
sodium;3-trimethylsilylpropane-1-sulonate |
CHEBI:195173 |
1-propanesulfonic acid, 3-(trimethylsilyl)- (sodium salt) |
BMSE000795 |
2,2-dimethyl-2-silapentane-5-sulfonate sodium salt |
sodium 3-(trimethylsilyl)propane-1-sulphonate hydrate |
nsc 83558 |
1-propanesulfonic acid, 3-(trimethylsilyl)-, sodium salt (1:1) |
einecs 218-031-5 |
FT-0633987 |
AKOS015904499 |
c6h15nao3ssi |
SCHEMBL424021 |
HWEXKRHYVOGVDA-UHFFFAOYSA-M |
DTXSID7062118 |
mfcd00007537 |
J-511036 |
AS-71314 |
sodium3-(trimethylsilyl)propane-1-sulfonate |
2,2-dimethyl-2-silapentane-5-sulfonic acid, sodium salt |
S07485 |
D84158 |
sodium;3-trimethylsilylpropane-1-sulfonate |
hematoporphyrindihydrochloride |
3-trimethylsilyl-1-propanesulfonic acid sodium salt |
trimethylsilylpropanesulfonic acid sodium salt, monohydrate |
trimethylsilylpropanesulfonicacid,sodiumsalt |
2,2-dimethyl-2-silapentane-5-sulfonic acid, sodium salt (dss) |
2,2-dimethyl-2-silapentane-5-sulfonic acid sodium salt |
996MF68A8L |
sodium 2,2'-dimethyl-2-silapentane-5-sulfonate |
sodium 4,4-dimethyl-4-silapentane-1-sulfonate |
sodium 4,4-dimethyl-4-silapentanesulfonate |
Excerpt | Relevance | Reference |
---|---|---|
" Both synthetic mixtures and dosage forms were assayed." | ( A quantitative NMR protocol for the simultaneous analysis of atropine and obidoxime in parenteral injection devices. Dubey, DK; Ganesan, K; Gupta, PK; Mazumder, A; Sharma, R; Vijayaraghavan, R, 2009) | 0.35 |
Role | Description |
---|---|
NMR chemical shift reference compound | Any compound that produces a peak used to reference an NMR spectrum during data pre-processing. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
organosulfonic acid | An organic derivative of sulfonic acid in which the sulfo group is linked directly to carbon. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (25.20) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |